Pliant Therapeutics, Inc.
PLRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $71 | $63 | $34 | $52 |
| Short-Term Investments | $285 | $431 | $298 | $149 |
| Receivables | $2 | $3 | $3 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $8 | $6 | $6 |
| Total Curr. Assets | $362 | $506 | $340 | $209 |
| Property Plant & Equip (Net) | $33 | $5 | $10 | $11 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $0 | $1 |
| Total NC Assets | $35 | $7 | $10 | $12 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $397 | $512 | $351 | $221 |
| Liabilities | – | – | – | – |
| Payables | $6 | $5 | $2 | $3 |
| Short-Term Debt | $1 | $1 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $27 | $23 | $20 | $12 |
| Total Curr. Liab. | $33 | $29 | $24 | $17 |
| LT Debt | $60 | $10 | $13 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $60 | $10 | $13 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $30 | $1 | $6 | $7 |
| Total Liabilities | $93 | $39 | $37 | $22 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$710 | -$500 | -$338 | -$215 |
| AOCI | $0 | $0 | -$2 | -$0 |
| Other Equity | $1,014 | $973 | $654 | $414 |
| Total Equity | $304 | $474 | $313 | $199 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $397 | $512 | $351 | $221 |
| Net Debt | -$11 | -$52 | -$18 | -$44 |